Genoma España launches a €4 Million line of credit
The beneficiaries are biotechnological companies searching for second rounds of investment and patent licensing companies.
BY BIOCAT
The Genoma España Foundation has launched a line of credit for biotechnological companies searching for second rounds of investment as complementary expansion to additional private funds (venture capital or investment capital), with a maximum of €450,000. Parallel, it has launched a second line of credit to facilitate patent licensing or shareholdings acquisition in High Tech Startups coming from projects funded by the Genoma España technological portfolio, until a maximum amount of €450,000.
The call is open while budget lasts or until 30th June 2012. In total, €4M will be allocated to this action by Genome.
- Call Bases
- Annex I: Loan request form
- Annex II: Agreement regulating the conditions attached to the loan
- Annex III: Investment commitment model
Related news: Genoma España, ICEX, CDTI and Asebio create USA Landing program (14/12/2011)